NCT07492485

Brief Summary

This study evaluated whether personalized dietary recommendations based on gut microbiome testing can improve intestinal health and food choices in adults with obesity in the region of Antioquia, Colombia. Fifty participants were randomly assigned to an intervention or control group. Outcomes included gut microbiome composition, blood biomarkers, weight, physical activity frequency, and dietary adherence over 12 weeks

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2024

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 25, 2026

Completed
Last Updated

March 25, 2026

Status Verified

July 1, 2023

Enrollment Period

8 months

First QC Date

March 12, 2026

Last Update Submit

March 19, 2026

Conditions

Keywords

Gut healthGut microbiome

Outcome Measures

Primary Outcomes (1)

  • Change in gut microbiota diversity (Shannon Index)

    Change in gut microbiota diversity assessed using the Shannon Diversity Index via 16S rRNA sequencing (V3-V4 region).

    Baseline and up to 3 months

Secondary Outcomes (9)

  • Change in glycated hemoglobin (HbA1c)

    Baseline and up to 3 months

  • Change in HDL cholesterol

    Baseline and up to 12 weeks

  • Change in LDL cholesterol

    Baseline and 12 weeks

  • Change in triglycerides

    Baseline and 12 weeks

  • Change in total cholesterol

    Baseline and 12 weeks

  • +4 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

Experimental Group

EXPERIMENTAL
Other: Personalized dietary recommendations

Interventions

Experimental: Personalized dietary intervention (n=25) Participants receive personalized dietary recommendations intended to improve gut microbiota diversity and metabolic health. Recommendations include increased dietary fiber intake, incorporation of fermented foods, reduced intake of added sugars and saturated fats, and increased consumption and variety of fruits and vegetables. Optional probiotic or prebiotic supplementation may be recommended. Adherence is monitored through periodic online questionnaires and regular phone or text message follow-ups. Precise nutrient intake and supplement dosages are not strictly quantified. Behavioral: Personalized dietary recommendations Individualized dietary guidance designed to promote gut microbiota diversity and metabolic health through increased fiber intake, fermented foods, reduced added sugars and saturated fats, and greater variety of fruits and vegetables. Optional probiotic or prebiotic supplementation may be included.

Experimental Group

Eligibility Criteria

Age23 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Affiliation with Comfama healthcare provider
  • Age between 23 and 65 years
  • Body Mass Index (BMI) ≥ 30 kg/m²
  • Residence in Medellín, Antioquia, Colombia
  • Willingness and ability to participate in the study for 12 weeks

You may not qualify if:

  • Pregnancy or lactation
  • History of bariatric surgery
  • Diagnosed mental health conditions
  • Use of specific medications (e.g., antidepressants, antibiotics)
  • Participation in a structured nutritional plan
  • Planned extended travel within the next 9 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Astrolab-bio

Medellín, Antioquia, 050022, Colombia

Location

MeSH Terms

Conditions

ObesityOverweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2026

First Posted

March 25, 2026

Study Start

July 10, 2023

Primary Completion

February 20, 2024

Study Completion

February 20, 2024

Last Updated

March 25, 2026

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

We will only share this information by demand of the journal were the study will be published or with other researchers from recognized institutions (according to their ORCID profile) that direclty ask for the data. All data will be anonymous.

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Beginning 1 year after publication with no end date
Access Criteria
The data will only be shared by demand with other researchers that belong to recognized institutions according to the ORCID affiliation. All data sharing will be anonymous.

Locations